On October 21, Gelunhui reported that Shanghai Kehua Bio-engineering (002022.SZ) announced its third quarter report in 2024. In the third quarter of 2024, the company achieved revenue of 0.442 billion yuan, a decrease of 13.01% year-on-year; the net income attributable to shareholders of the listed company was a loss of 69.6766 million yuan, a decrease of 69.60% year-on-year; the net income after deducting non-recurring gains and losses was a loss of 70.3352 million yuan, a decrease of 57.25% year-on-year; and the basic earnings per share was a loss of 0.1378 yuan per share.